Supported Research
-
FRIENDS brings together 19 institutions to create a shared resource for FA research. This award supports organizing clinical information consistently across institutions and piloting contributions of electronic health records from individuals. The resource will help researchers study cancer, transplant effects, fertility and other aspects of...
-
This award supports an early clinical study of transplantation before birth using blood-forming stem cells from the mother. Researchers will study maternal and fetal safety and whether the transplanted cells establish lasting blood cell production. The approach aims to address blood and marrow disease; its...
-
Researchers are developing a method to insert a functioning gene into FA blood-forming cells. Studies in cells and mouse models will evaluate the approach, with the longer-term goal of making gene correction possible directly in the body. This work remains preclinical.
-
This project explores ways to intercept formaldehyde, a substance produced naturally in the body, before it damages DNA. Using laboratory and animal models of FA, researchers will test whether sustained drug treatment can help protect against bone marrow failure and leukemia.
-
Aldehydes are substances produced during normal metabolism that can damage DNA. This project investigates ways to boost ALDH9A1, an enzyme that helps break them down. Researchers will look for drugs that activate the enzyme and test whether they can protect FA blood-forming cells from damage.
-
This project builds on research using organoids, small, lab-grown models of healthy, precancerous and cancerous tissue from people with FA. Researchers will evaluate promising drug candidates to determine how selectively they affect cancer cells and whether they cause DNA damage. The goal is to identify...
-
Researchers will study whether abnormal amounts of DNA and other biological changes in cells collected with an oral brush can help identify lesions that need closer evaluation. Following these changes over time may improve understanding of oral cancer risk and help guide future screening approaches...
-
This award continues a comprehensive cancer screening program that has enrolled more than 100 people with FA. By combining regular screening with the collection of samples over time, researchers aim to better understand how cancer develops and identify potential early warning signs. The project also...
-
This clinical study examines the safety and tolerability of metformin and naproxen as potential approaches to oral cancer prevention in people with FA. Participants take the medications during separate study periods. Researchers will monitor side effects and changes in oral tissue to look for early...
-
People with Fanconi anemia (FA) face a high risk of cancer, but their difficulty repairing DNA can make some cancer treatments especially harmful. This project examines two questions: Which compounds might help prevent cancer, and which cancer treatment drugs might be safer for people with...
The Latest
News & Events
Ford loved his Mama and Daddy. He lit up anytime his Grandma, Grandpa or hospice nurse, Molly, came into the room. He loved the color blue, his stuffed animal giraffe and his puppy dog brother, Boats. He had the craziest, cutest, fluffiest hair and almost always had a binky in his mouth. When he didn’t, he was sticking out his tongue or smiling with his whole face. His nursery is decorated with moons, planets and stars. He was always bigger than the whole sky.
Czechowicz lab at Stanford Promising research needs continued support to answer the next question. A laboratory finding may need testing in more models. A screening study may need years of follow-up. An approach ready for a clinical study needs the...
How can we prevent cancer in people with FA? How can treatments become safer? At the 2026 FA Scientific Symposium in Phoenix, researchers shared progress toward answering these questions, alongside work to protect blood-forming cells and better understand the broader effects of FA. Some approaches are entering clinical studies. Others are helping researchers decide which ideas deserve further testing.